4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-108154
Chief Operating Officer sold 8,976 shares at $34.41 ($308,864)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-09-18 | Sale 10b5-1 | −4,340 | $34.41 | $149,339 | 136,272 | D |
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-09-18 | Sale 10b5-1 | −4,636 | $34.41 | $159,525 | 131,636 | D |
| Open-market sales · 8,976 sh · avg $34.41 · $308,864 | |||||||
Loading xslF345X05/ownership.xml…